Reported impact
Business outcome
Biofy reduced treatment recommendation time from roughly five days to about four hours, improved performance by 50 percent at up to half the cost of alternative cloud providers, raised diagnostic accuracy to 95–97 percent, and has already supported several thousand tests while reportedly helping save more than a hundred lives.
- Cost Reduction
- Productivity Improvement
- Risk Reduction
Solution
Biofy built a cloud-native genomic diagnostics pipeline on Oracle Cloud Infrastructure and NVIDIA acceleration to compress multi-day infectious-disease workflows into hours. Full-genome DNA sequences are assembled with NVIDIA-accelerated algorithms, embedded as vectors, and matched against large microbial-genome and resistance-marker databases. Abby, Biofy’s recommendation engine, then analyzes the detected resistance genes and suggests the most effective antibiotics or treatment path for the specific infection. Under the hood, Biofy uses NVIDIA RAPIDS, NVIDIA cuDF, NVIDIA cuML, CUDA-accelerated libraries, and 32 H100 Tensor Core GPUs to run large-scale DNA matrix operations, model training, and inference. Oracle Autonomous AI Database and Oracle AI Vector Search store and retrieve genomic vectors, while the platform also generates more than 100,000 synthetic DNA sequences to keep resistance models current as bacteria mutate.
Data flow
Hospitals sequence bacterial DNA, OCI-hosted NVIDIA pipelines assemble full genomes and convert them into vectors, Oracle stores and searches those vectors against microbial and resistance databases, and Abby returns pathogen identification plus antibiotic recommendations into the clinical workflow.